Bayer glucose meter aimed at gamers

Share this article:
Bayer glucose meter aimed at gamers
Bayer glucose meter aimed at gamers
Bayer Diabetes Care partnered with Nintendo on a glucose meter for kids that incorporates gaming.

Bayer's Didget meter plugs into the Nintendo DS and DS Lite handheld gaming systems, where kids can use points earned by consistent testing on unlocking levels in a game called Knock 'Em Downs: World's Fair. The meter, aimed at kids ages 4-14, will also connect to Bayer's password protected web community bayerdidget.com.

An extension of Bayer's Contour line of meters, it launched in the UK last summer and will retail in drug stores for a suggested price of $74.99.

The company is keeping quiet about its advertising plans – a spokeswoman would allow only that “We do have a robust promotional program planned.” Bayer, which recently consolidated its healthcare advertising into Omnicom and WPP, uses BBDO for consumer advertising and Cline, Davis & Mann for professional.

Contour USB meter user and Bayer diabetes “ambassador” Nick Jonas is, at 17, too old for the device, but was quoted in a release plugging the Didget as a “cool and fun way” for kids to test their blood sugar, and noting that it “uses the same test strips as the Contour meter, the strips I rely on every day.”
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.